Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Insufficiency of urinary acid excretion of overweight or obese patients with chronic kidney disease and its involvement with renal tubular injury.

Eguchi K, Izumi Y, Nakayama Y, Inoue H, Marume T, Matsuo N, Hiramatsu A, Ono M, Kakizoe Y, Kuwabara T, Nonoguchi H, Mukoyama M.

Nephrology (Carlton). 2018 Dec 23. doi: 10.1111/nep.13553. [Epub ahead of print]

PMID:
30582257
2.

Fludrocortisone stimulates erythropoietin production in the intercalated cells of the collecting ducts.

Yasuoka Y, Izumi Y, Nagai T, Fukuyama T, Nakayama Y, Inoue H, Horikawa K, Kimura M, Nanami M, Yanagita K, Oshima T, Yamazaki T, Uematsu T, Yamamura R, Kobayashi N, Shimada Y, Nagaba Y, Nakanishi T, Yamashita T, Mukoyama M, Sato Y, Kawahara K, Nonoguchi H.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):3121-3127. doi: 10.1016/j.bbrc.2018.08.102. Epub 2018 Aug 23.

3.

TSS-Seq analysis of low pH-induced gene expression in intercalated cells in the renal collecting duct.

Izumi Y, Inoue H, Nakayama Y, Eguchi K, Yasuoka Y, Matsuo N, Nonoguchi H, Kakizoe Y, Kuwabara T, Mukoyama M.

PLoS One. 2017 Aug 31;12(8):e0184185. doi: 10.1371/journal.pone.0184185. eCollection 2017.

4.

Edoxaban was Effective for Treating Renal Vein Thrombosis in a Patient with Nephrotic Syndrome.

Shimada Y, Nagaba Y, Nagaba H, Kamata M, Murano J, Kamata F, Okina C, Nonoguchi H, Shimada H, Takeuchi Y.

Intern Med. 2017 Sep 1;56(17):2307-2310. doi: 10.2169/internalmedicine.8742-16. Epub 2017 Aug 10.

5.

Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and Helicobacter pylori Infection in Gastric Cancer.

Fukuyama T, Futawatari N, Ichiki Y, Shida A, Yamazaki T, Nishi Y, Nonoguchi H, Takahashi Y, Yamazaki H, Kobayashi N.

In Vivo. 2017 May-Jun;31(3):403-407.

6.

pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney.

Yasuoka Y, Sato Y, Healy JM, Nonoguchi H, Kawahara K.

Clin Exp Nephrol. 2015 Oct;19(5):771-82. doi: 10.1007/s10157-014-1063-1. Epub 2014 Dec 13.

PMID:
25500736
7.

Expression of three isoforms of Na-K-2Cl cotransporter (NKCC2) in the kidney and regulation by dehydration.

Itoh K, Izumi Y, Inoue T, Inoue H, Nakayama Y, Uematsu T, Fukuyama T, Yamazaki T, Yasuoka Y, Makino T, Nagaba Y, Tomita K, Kobayashi N, Kawahara K, Mukoyama M, Nonoguchi H.

Biochem Biophys Res Commun. 2014 Oct 24;453(3):356-61. doi: 10.1016/j.bbrc.2014.09.089. Epub 2014 Sep 27.

PMID:
25265491
8.

Reevaluation of erythropoietin production by the nephron.

Nagai T, Yasuoka Y, Izumi Y, Horikawa K, Kimura M, Nakayama Y, Uematsu T, Fukuyama T, Yamazaki T, Kohda Y, Hasuike Y, Nanami M, Kuragano T, Kobayashi N, Obinata M, Tomita K, Tanoue A, Nakanishi T, Kawahara K, Nonoguchi H.

Biochem Biophys Res Commun. 2014 Jun 27;449(2):222-8. doi: 10.1016/j.bbrc.2014.05.014. Epub 2014 May 14.

9.

Combined angiotensin inhibition in diabetic nephropathy.

Izumi Y, Kawahara K, Nonoguchi H.

N Engl J Med. 2014 Feb 20;370(8):777-8. doi: 10.1056/NEJMc1315504. No abstract available.

PMID:
24552330
10.

Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome.

Klootwijk ED, Reichold M, Helip-Wooley A, Tolaymat A, Broeker C, Robinette SL, Reinders J, Peindl D, Renner K, Eberhart K, Assmann N, Oefner PJ, Dettmer K, Sterner C, Schroeder J, Zorger N, Witzgall R, Reinhold SW, Stanescu HC, Bockenhauer D, Jaureguiberry G, Courtneidge H, Hall AM, Wijeyesekera AD, Holmes E, Nicholson JK, O'Brien K, Bernardini I, Krasnewich DM, Arcos-Burgos M, Izumi Y, Nonoguchi H, Jia Y, Reddy JK, Ilyas M, Unwin RJ, Gahl WA, Warth R, Kleta R.

N Engl J Med. 2014 Jan 9;370(2):129-38. doi: 10.1056/NEJMoa1307581.

11.

Effects of atrial natriuretic peptide on bicarbonate transport in long- and short-looped medullary thick ascending limbs of rats.

Nonoguchi H, Izumi Y, Nakayama Y, Matsuzaki T, Yasuoka Y, Inoue T, Inoue H, Mouri T, Kawahara K, Saito H, Tomita K.

PLoS One. 2013 Dec 23;8(12):e83146. doi: 10.1371/journal.pone.0083146. eCollection 2013.

12.

The intercalated cells of the mouse kidney OMCD(is) are the target of the vasopressin V1a receptor axis for urinary acidification.

Yasuoka Y, Kobayashi M, Sato Y, Zhou M, Abe H, Okamoto H, Nonoguchi H, Tanoue A, Kawahara K.

Clin Exp Nephrol. 2013 Dec;17(6):783-92. doi: 10.1007/s10157-013-0783-y. Epub 2013 Mar 1.

PMID:
23456233
13.

Association of chronic kidney disease with adverse outcomes.

Izumi Y, Ogawa M, Itoh H, Shimada H, Nonoguchi H.

Lancet. 2013 Feb 16;381(9866):531. doi: 10.1016/S0140-6736(13)60271-8. No abstract available.

PMID:
23415296
14.

Vasopressin V1a and V1b receptors: from molecules to physiological systems.

Koshimizu TA, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A.

Physiol Rev. 2012 Oct;92(4):1813-64. doi: 10.1152/physrev.00035.2011. Review.

15.

Decreased expression of aquaporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor.

Yasuoka Y, Kobayashi M, Sato Y, Nonoguchi H, Tanoue A, Okamoto H, Kawahara K.

Clin Exp Nephrol. 2013 Apr;17(2):183-90. doi: 10.1007/s10157-012-0686-3. Epub 2012 Sep 12.

PMID:
22968856
16.

Vasopressin V1a receptor is required for nucleocytoplasmic transport of mineralocorticoid receptor.

Hori K, Nagai T, Izumi Y, Kimura M, Hasuike Y, Nakayama Y, Nanami M, Tokuyama M, Otaki Y, Kuragano T, Kohda Y, Obinata M, Kawahara K, Tanoue A, Tomita K, Nakanishi T, Nonoguchi H.

Am J Physiol Renal Physiol. 2012 Oct;303(7):F1080-8. doi: 10.1152/ajprenal.00052.2012. Epub 2012 Jul 18.

17.

High levels of tumor necrosis factor-α downregulate antimicrobial iron transport protein, Nramp1, in chronic hemodialysis patients: a key factor for infection risk.

Moriguchi R, Otaki Y, Hazeki S, Shimada T, Matsumoto A, Kakita N, Kaibe S, Kuragano T, Nonoguchi H, Masayoshi N, Hasuike Y, Nakanishi T.

Am J Nephrol. 2012;35(4):372-8. doi: 10.1159/000337742. Epub 2012 Apr 12.

PMID:
22508410
18.

The impact of ferritin fluctuations on stable hemoglobin levels in hemodialysis patients.

Yahiro M, Kuragano T, Kida A, Kitamura R, Furuta M, Hasuike Y, Otaki Y, Nonoguchi H, Nakanishi T.

Clin Exp Nephrol. 2012 Jun;16(3):448-55. doi: 10.1007/s10157-011-0584-0. Epub 2012 Jan 24.

PMID:
22270185
19.

Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients.

Kuragano T, Kida A, Furuta M, Yahiro M, Kitamura R, Otaki Y, Nonoguchi H, Matsumoto A, Nakanishi T.

Artif Organs. 2012 Mar;36(3):282-90. doi: 10.1111/j.1525-1594.2011.01349.x. Epub 2011 Sep 29. Erratum in: Artif Organs. 2013 Aug;37(8):746.

PMID:
21954915
20.

Hepcidin: another culprit for complications in patients with chronic kidney disease?

Nakanishi T, Hasuike Y, Otaki Y, Kida A, Nonoguchi H, Kuragano T.

Nephrol Dial Transplant. 2011 Oct;26(10):3092-100. doi: 10.1093/ndt/gfr410. Epub 2011 Jul 22. Review.

PMID:
21785039
21.

Persistent homocysteine metabolism abnormality accelerates cardiovascular disease in hemodialyzed patients--the Nishinomiya Study.

Hasuike Y, Hama Y, Nonoguchi H, Hori K, Tokuyama M, Toyoda K, Hazeki S, Nanami M, Otaki Y, Kuragano T, Nakanishi T.

J Ren Nutr. 2012 Jan;22(1):12-8.e1. doi: 10.1053/j.jrn.2011.04.005. Epub 2011 Jul 12.

PMID:
21752669
22.

Toxicodynamic evaluation of a cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells.

Zhang JS, Kadowaki D, Nonoguchi H, Hirata S, Seo H, Imai T, Suenaga A, Giam Chuang VT, Otagiri M.

Ren Fail. 2011;33(6):609-14. doi: 10.3109/0886022X.2011.585266. Epub 2011 Jun 1.

PMID:
21631182
23.

A crossover study of the acrylonitrile-co-methallyl sulfonate and polysulfone membranes for elderly hemodialysis patients: the effect on hemodynamic, nutritional, and inflammatory conditions.

Furuta M, Kuragano T, Kida A, Kitamura R, Nanami M, Otaki Y, Nonoguchi H, Matsumoto A, Nakanishi T.

ASAIO J. 2011 Jul-Aug;57(4):293-9. doi: 10.1097/MAT.0b013e31821796f1.

PMID:
21499075
24.

Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis.

Izumi Y, Hori K, Nakayama Y, Kimura M, Hasuike Y, Nanami M, Kohda Y, Otaki Y, Kuragano T, Obinata M, Kawahara K, Tanoue A, Tomita K, Nakanishi T, Nonoguchi H.

J Am Soc Nephrol. 2011 Apr;22(4):673-80. doi: 10.1681/ASN.2010050468. Epub 2011 Mar 17.

25.

Therapeutic efficacy of double filtration plasmapheresis in patients with anti-aquaporin-4 antibody-positive multiple sclerosis.

Munemoto M, Otaki Y, Kasama S, Nanami M, Tokuyama M, Yahiro M, Hasuike Y, Kuragano T, Yoshikawa H, Nonoguchi H, Nakanishi T.

J Clin Neurosci. 2011 Apr;18(4):478-80. doi: 10.1016/j.jocn.2010.07.141. Epub 2011 Feb 18.

PMID:
21315606
26.

Pathological role of aminolevulinate in uremic patients.

Hasuike Y, Nonoguchi H, Tokuyama M, Hata R, Kitamura R, Hori K, Nanami M, Otaki Y, Kuragano T, Nakanishi T.

Ther Apher Dial. 2011 Feb;15(1):28-33. doi: 10.1111/j.1744-9987.2010.00824.x.

PMID:
21272249
27.

Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis.

Kuragano T, Itoh K, Shimonaka Y, Kida A, Furuta M, Kitamura R, Yahiro M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T.

Nephrol Dial Transplant. 2011 Aug;26(8):2663-7. doi: 10.1093/ndt/gfq760. Epub 2011 Jan 18.

PMID:
21245128
28.

Importance of ferritin for optimizing anemia therapy in chronic kidney disease.

Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y.

Am J Nephrol. 2010;32(5):439-46. doi: 10.1159/000320733. Epub 2010 Sep 30. Review.

29.

A case of a maintenance hemodialysis patient in whom a change of sensitivity to acetate was suspected.

Kuragano T, Furuta M, Kida A, Kitamura R, Nanami M, Otaki Y, Nonoguchi H, Nakanishi T.

ASAIO J. 2010 Sep-Oct;56(5):488-90. doi: 10.1097/MAT.0b013e3181f11e9d.

PMID:
20811173
30.

Kidney function, proteinuria, and adverse outcomes.

Nonoguchi H, Nanami M, Nakanishi T.

JAMA. 2010 May 26;303(20):2030; author reply 2030. doi: 10.1001/jama.2010.656. No abstract available.

PMID:
20501920
31.

Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.

Kuragano T, Shimonaka Y, Kida A, Furuta M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T.

Am J Nephrol. 2010;31(6):534-40. doi: 10.1159/000312381. Epub 2010 May 14.

PMID:
20484891
32.

Serum ferritin predicts prognosis in hemodialysis patients: the Nishinomiya study.

Hasuike Y, Nonoguchi H, Tokuyama M, Ohue M, Nagai T, Yahiro M, Nanami M, Otaki Y, Nakanishi T.

Clin Exp Nephrol. 2010 Aug;14(4):349-55. doi: 10.1007/s10157-010-0288-x. Epub 2010 May 14.

PMID:
20467772
33.

The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients.

Kuragano T, Kida A, Furuta M, Nanami M, Otaki Y, Hasuike Y, Nonoguchi H, Nakanishi T.

ASAIO J. 2010 Jul-Aug;56(4):326-32. doi: 10.1097/MAT.0b013e3181de0842.

PMID:
20431482
34.

Interleukin-6 is a predictor of mortality in stable hemodialysis patients.

Hasuike Y, Nonoguchi H, Ito K, Naka M, Kitamura R, Nanami M, Tokuyama M, Kida A, Otaki Y, Kuragano T, Nakanishi T.

Am J Nephrol. 2009;30(4):389-98. doi: 10.1159/000235687. Epub 2009 Aug 19.

PMID:
19690405
35.

Epoetins and mortality in patients with cancer.

Nonoguchi H, Otaki Y, Tokuyama M, Yamamoto S, Nakanishi T.

Lancet. 2009 Jul 25;374(9686):287; author reply 287-8. doi: 10.1016/S0140-6736(09)61356-8. No abstract available.

PMID:
19632484
36.

Low pH stimulates vasopressin V2 receptor promoter activity and enhances downregulation induced by V1a receptor stimulation.

Memetimin H, Izumi Y, Nakayama Y, Kohda Y, Inoue H, Nonoguchi H, Tomita K.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F620-8. doi: 10.1152/ajprenal.90520.2008. Epub 2009 Jul 8.

37.

Enhanced kidney, gallbladder and colon on delayed CT.

Munemoto M, Kawai K, Yamamoto S, Nonoguchi H, Nakanishi T.

Nephrology (Carlton). 2009 Apr;14(3):360. doi: 10.1111/j.1440-1797.2009.01071.x. No abstract available.

PMID:
19426362
38.

Vasopressin and hyperosmolality regulate NKCC1 expression in rat OMCD.

Wakamatsu S, Nonoguchi H, Ikebe M, Machida K, Izumi Y, Memetimin H, Nakayama Y, Nakanishi T, Kohda Y, Tomita K.

Hypertens Res. 2009 Jun;32(6):481-7. doi: 10.1038/hr.2009.52. Epub 2009 Apr 24.

PMID:
19390537
39.

Acute and chronic metabolic acidosis interferes with aquaporin-2 translocation in the rat kidney collecting ducts.

Mouri T, Inoue T, Nonoguchi H, Nakayama Y, Miyazaki H, Matsuzaki T, Saito H, Nakanishi T, Kohda Y, Tomita K.

Hypertens Res. 2009 May;32(5):358-63. doi: 10.1038/hr.2009.19. Epub 2009 Mar 20.

PMID:
19300448
40.

Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms.

Nakayama Y, Nonoguchi H, Kohda Y, Inoue H, Memetimin H, Izumi Y, Tomita K.

Nephron Clin Pract. 2009;111(4):c240-6. doi: 10.1159/000209150. Epub 2009 Mar 17.

PMID:
19293592
41.

A case with acute renal failure and subsequent nephrotic syndrome.

Nonoguchi H, Kohda Y, Fukutomi R, Nakayama Y, Naruse M, Kitamura K, Inoue T, Nakanishi T, Tomita K.

Ren Fail. 2009;31(2):162-6. doi: 10.1080/08860220802595955.

PMID:
19212916
42.

Renal outcomes in the ONTARGET study.

Nonoguchi H, Nanami M, Hasuike Y, Kuragano T, Nakanishi T.

Lancet. 2008 Dec 13;372(9655):2019-20; author reply 2020-1. doi: 10.1016/S0140-6736(08)61861-9. No abstract available.

PMID:
19070731
43.

Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.

Izumi Y, Nakayama Y, Memetimin H, Inoue T, Kohda Y, Nonoguchi H, Tomita K.

Am J Physiol Renal Physiol. 2008 Oct;295(4):F1170-6. doi: 10.1152/ajprenal.00119.2008. Epub 2008 Aug 13.

44.

Long-term observation of renal function on combination therapy with prostaglandin and angiotensin-converting enzyme inhibitor for chronic kidney disease.

Nakayama Y, Inoue T, Kohda Y, Inoue H, Izumi Y, Tomita K, Nonoguchi H.

Clin Nephrol. 2008 Jun;69(6):402-7.

PMID:
18538115
45.

Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells.

Aoyagi T, Izumi Y, Hiroyama M, Matsuzaki T, Yasuoka Y, Sanbe A, Miyazaki H, Fujiwara Y, Nakayama Y, Kohda Y, Yamauchi J, Inoue T, Kawahara K, Saito H, Tomita K, Nonoguchi H, Tanoue A.

Am J Physiol Renal Physiol. 2008 Jul;295(1):F100-7. doi: 10.1152/ajprenal.00088.2008. Epub 2008 Apr 30.

46.

Functional and immunochemical characterization of a novel organic anion transporter Oat8 (Slc22a9) in rat renal collecting duct.

Yokoyama H, Anzai N, Ljubojevic M, Ohtsu N, Sakata T, Miyazaki H, Nonoguchi H, Islam R, Onozato M, Tojo A, Tomita K, Kanai Y, Igarashi T, Sabolic I, Endou H.

Cell Physiol Biochem. 2008;21(4):269-78. doi: 10.1159/000129385. Epub 2008 Apr 23.

47.

Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure.

Nonoguchi H, Kiyama S, Kitamura K, Naruse M, Tomita M, Tazoe N, Tajiri M, Nakayama Y, Kohda Y, Inoue T, Tomita K.

Hypertens Res. 2008 Jan;31(1):29-36. doi: 10.1291/hypres.31.29.

PMID:
18360015
48.

The MAXIMA trial.

Nonoguchi H, Izumi Y, Nakayama Y, Kohda Y, Tomita K.

Lancet. 2008 Jan 26;371(9609):299-300; author reply 300. doi: 10.1016/S0140-6736(08)60160-9. No abstract available.

PMID:
18294989
49.

Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.

Matsuzaki T, Morisaki T, Sugimoto W, Yokoo K, Sato D, Nonoguchi H, Tomita K, Terada T, Inui K, Hamada A, Saito H.

Drug Metab Dispos. 2008 Apr;36(4):649-54. doi: 10.1124/dmd.107.019869. Epub 2008 Jan 7.

PMID:
18180268
50.

Low-responders to angiotensin II receptor blockers and genetic polymorphism in angiotensin-converting enzyme.

Nonoguchi H, Nakayama Y, Shiigai T, Inoue T, Inoue H, Kohda Y, Honda Y, Tomita K.

Clin Nephrol. 2007 Oct;68(4):209-15.

PMID:
17969487

Supplemental Content

Loading ...
Support Center